Assessment of complement activation during membrane-based plasmapheresis procedures

Journal of Clinical Apheresis

Volumn 19, Issue 3, 2004, Pages 142-147

  Burnouf, Thierry ^a   Eber, Michel ^b   Kientz, Daniel ^c   Cazenave, Jean Pierre ^c   Burkhardt, Thomas ^d  

^a HUMAN PROTEIN PROCESS SCIENCES   (France)

^b CENTRE PAUL STRAUSS   (France)

^c ETABLISSEMENT FRANÇAIS DU SANG   (France)

^d Red Cross Blood Transfus Ctr S   (Germany)

Author keywords

Apheresis; C3a; C5a; Complement; Plasma

Indexed keywords

ANAPHYLATOXIN; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C3A [DEARGININE]; COMPLEMENT COMPONENT C5A; COMPLEMENT COMPONENT C5A [DEARGININE]; NYLON; POLYETHERSULFONE; UNCLASSIFIED DRUG;

ARTICLE; ARTIFICIAL MEMBRANE; BIOCOMPATIBILITY; BLOOD DONOR; BLOOD FILTRATION; CENTRIFUGATION; COMPLEMENT ACTIVATION; DEVICE; FRANCE; GRAVITY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; PLASMAPHERESIS; POROSITY; ROTATION;

COMPLEMENT ACTIVATION; COMPLEMENT C3A; COMPLEMENT C5A; HUMANS; PLASMAPHERESIS;

EID: 6344229753     PISSN: 07332459     EISSN: None     Source Type: Journal    
DOI: 10.1002/jca.20019     Document Type: Article

References (30)

1. Snyder EL, Root RK, McLeod B, Dalmasso AP. Activation of complement by blood transfusion filters. Vox Sang 1983;45:288-293.
2. Schooneman F, Marchand M, Vigneron C, Streiff F. Determination of C3a and C5a in hemapheresis procedures. (in French) Ann Med Interne (Paris) 1990;141:597-599.
3. Vogt W. Anaphylatoxins: possible roles in disease. Complement 1986;3:177-188.
4. Sonntag J, Stiller B, Walka MM, Maier RF. Anaphylatoxins in fresh-frozen plasma. Transfusion 1997;37:798-803.
5. Sonntag J, Emeis M, Vornwald A, Strauss E, Maier RF. Complement activation during plasma production depends on the apheresis technique. Transfus Med 1998;8:205-208.
6. Burnouf T, Kappelsberger C, Frank K, Burkhardt T. Protein composition and activation markers in plasma collected by three apheresis procedures. Transfusion 2003;43:1223-1230.
7. Burnouf T, Kappelsberger C, Frank K, Burkhardt T. Residual cell content in plasma from 3 centrifugal apheresis procedures. Transfusion 2003;11:1522-1526.
8. Burgstaler E. Current Instrumentation for Apheresis. In: McLeod BC, Price TH, Weinstein RE, editors. Apheresis: Principles and Practice, 2nd Edition: AABB Press; 2003. p 95-130.
9. Baxter Healthcare. Autopheresis-C plasmapheresis system service manual. Deerfield IL: Baxter Healthcare Corporation, Fenwal Division 1999.
10. Burnouf T, Caron C, Burkhardt JJ, Goudemand J. Content and functional activity of von Willebrand factor in apheresis plasma. Vox Sang 2004;87:27-33.
11. Omokawa S, Malchesky PS, Yamashita M, Suzuki T, Goldcamp JG, Murabayashi S, Nose Y. Effect of anticoagulant on biocompatibility in membrane plasmapheresis. Int J Artif Organs 1990;13:768-777.
12. Gu YJ, Van Oeveren W. Activation of plasma components by leukocyte removal filters. Asaio J 1994;40:M598-601.
13. Hetland G, Mollnes TE, Larsen J, Garred P. Biocompatibility of white cell filters as evaluated by complement activation. Transfusion 1992;32:557-561.
14. Cardigan R, Sutherland J, Garwood M, Krailadsiri P, Seghatchian J, Beard M, Beckman N, Williamson LM. The effect of leucocyte depletion on the quality of fresh-frozen plasma. Br J Haematol 2001;114:233-240.
15. Shimizu T, Uchigiri C, Mizuno S, Kamiya T, Kokubo Y. Adsorption of anaphylatoxins and platelet-specific proteins by filtration of platelet concentrates with a polyester leukocyte reduction filter. Vox Sang 1994;66:161-165.
16. Snyder EL, Mechanic S, Baril L, Davenport R. Removal of soluble biologic response modifiers (complement and chemokines) by a bedside white cell-reduction filter. Transfusion 1996;36:707-713.
17. Geiger TL, Perrotta PL, Davenport R, Baril L, Snyder EL. Removal of anaphylatoxins C3a and C5a and chemokines interleukin 8 and RANTES by polyester white cell-reduction and plasma filters. Transfusion 1997;37:1156-1162.
18. Hyllner M, Tylman M, Bengtson JP, Rydberg L, Bengtsson A. Complement activation in prestorage leucocyte-filtered plasma. Transfus Med 2004;14:45-52.
19. Perseghin P, Capra M, Baldini V, Sciorelli G. Bradykinin production during donor plasmapheresis procedures. Vox Sang 2001;81:24-28.
20. Hoffmann T, Bottger EC, Baum HP, Messner M, Hadding U, Bitter-Suermann D. In vivo effects of C3a on neutrophils and its contribution to inflammatory lung processes in a guinea-pig model. Clin Exp Immunol 1988;71:486-492.
21. Watson JW, Drazen JM, Stimler-Gerard NP. Synergism between inflammatory mediators in vivo. Induction of airway hyperresponsiveness to C3a in the guinea pig. Am Rev Respir Dis 1988;137:636-640.
22. Johnson RJ, Burhop KE, Van Epps DE. Infusion of ovine C5a into sheep mimics the inflammatory response of hemodialysis. J Lab Clin Med 1996;127:456-469.
23. Regal JF, Fraser DG, Toth CA. Role of the complement system in antigen-induced bronchoconstriction and changes in blood pressure in the guinea pig. J Pharmacol Exp Ther 1993;267:979-988.
24. Mulligan MS, Schmid E, Beck-Schimmer B, Till GO, Friedl HP, Brauer RB, Hugli TE, Miyasaka M, Warner RL, Johnson KJ, Ward PA. Requirement and role of C5a in acute lung inflammatory injury in rats. J Clin Invest 1996;98:503-512.
25. Weisdorf DJ, Hammerschmidt DE, Jacob HS, Craddock PR. Rapid in vivo clearance of C5ades arg: a possible protective mechanism against complement-mediated tissue injury. J Lab Clin Med 1981;98:823-830.
26. Smith JK. Quality of plasma for fractionation: does it matter? Transfus Sci 1994;15:343-350.
27. Pejaudier L, Kichenin-Martin V, Boffa MC, Steinbuch M. Appraisal of the protein composition of prothrombin complex concentrates of different origins. Vox Sang 1987;52:1-9.
28. Edell S. Anaphylaxis after Konyne. N Engl J Med 1971;285:580.
29. Weinreb NJ, Minsky N. Serious reaction after Konyne. N Engl J Med 1971;285:1151-1152.
30. Fukumoto Y, Tsumoto K, Tashiro A, Ohtomo N, Yoshida T. Distributions and recoveries of complement components during cold ethanol fractionation of human plasma. Complement 1984;1:177-181.